Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal clonidine or dexmedetomidine added to ropivacaine for subarachnoid block in infra-umbilical surgery
ACTRN12612000581864Phase 4Recruiting
- Sponsor
- Safdarjung Hospital
- Start
- Apr 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine, clonidine and dexmedetomidine in pain (3 arms), sponsored by Safdarjung Hospital. Primary endpoints: Duration of sensory block and Total duration of analgesia. Started Apr 2012; status: recruiting.
02
Drugs
ropivacaineclonidinedexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on ACTRN12612000581864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000581864.